Dianthus Therapeutics, Inc. (DNTH) stock analysis
DNTH · Dianthus Therapeutics, Inc.
Latest recorded price: USD 89.55
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: free cash flow margin -6,349.4%, ROIC -32.0%. The model flags 2 risk signals for this company (2 high severity).